Evidence map›Paper›PMID 35979417›Full record

ArticleWorld journal of gastrointestinal surgery2022

Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension.

Xuan-Hui Yan, Zhen-Dong Yue, Hong-Wei Zhao, Lei Wang, Zhen-Hua Fan, Yi-Fan Wu, Ming-Ming Meng, Ke Zhang, Li Jiang, Hui-Guo Ding and 3 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastrointestinal surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Xuan-Hui YanDepartment of Interventional Therapy, Peking University Ninth School of Clinical Medicine, Beijing Shijitan Hospital, Beijing 100038, China.
Zhen-Dong YueDepartment of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Hong-Wei ZhaoDepartment of Interventional Therapy, Beijing Tongren Hospital, Capital Medical University, Beijing 100005, China.
Lei WangDepartment of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Zhen-Hua FanDepartment of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Yi-Fan WuDepartment of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Ming-Ming MengDepartment of Gastroenterology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Ke ZhangDepartment of General Surgery, Beijing Ditan Hospital, Capital Medical University, Beijing 100102, China.
Li JiangDepartment of General Surgery, Beijing Ditan Hospital, Capital Medical University, Beijing 100102, China.
Hui-Guo DingDepartment of Gastroenterology, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
Yue-Ning ZhangDepartment of Liver Disease Digestion Center, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China.
Yong-Ping YangDepartment of Liver Disease, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China.
Fu-Quan LiuDepartment of Interventional Therapy, Peking University Ninth School of Clinical Medicine, Beijing Shijitan Hospital, Beijing 100038, China.
Capital Medical University · CNBeijing Ditan Hospital · CNBeijing Shijitan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with hepatocellular carcinoma complicated with main portal vein tumor thrombosis (mPVTT) and cirrhotic portal hypertension (CPH) have an extremely poor prognosis, and there is a lack of a clinically effective treatment paradigm.

aimTo evaluate the efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) combined with radioactive seed strand for the treatment of mPVTT patients with CPH.

methodsThe clinical data of 83 consecutive patients who underwent TIPS combined with

resultsThe success rate was 100.0% without perioperative death or procedure-related severe adverse events. The mean portal vein pressure was significantly decreased after the procedure (22.25 ± 7.33 mmHg

conclusionTIPS combined with radioactive seed strand might be effective and safe in treating mPVTT patients with CPH.

Indexed as

CirrhosisCirrhotic portal hypertensionHepatocellular carcinomaPortal vein tumor thrombosisRadioactive seed strandTransjugular intrahepatic portosystemic shunt

Identifiers

PMID35979417
PMCPMC9258232
OpenAlexW4283587513

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.